Biogradient
Digital Sensor-based System for Maximizing Personalized Physiological Capabilities
Health Tech & Life Sciences
Non Active, Mar 2025 ceased to operate
Company Overview
Snapshot
Founded in May 2019 by Ron Gutterman and Gal Tichon, Biogradient operates with 11–50 employees. The company ceased operations in March 2025.
Business overview
Biogradient develops physiological algorithms and artificial intelligence for applications in medicine, sports, and insurance. Its core technology provides a digital sensor-based system designed for personalized, goal-oriented exercise prescription and remote monitoring. The company serves the Health Tech & Life Sciences sector, focusing on digital healthcare, and operates within the artificial intelligence, deep learning, and sensing technology categories.
Company Intelligence Q&A
- What is Biogradient's primary focus?
- Biogradient focuses on developing physiological algorithms and artificial intelligence to maximize personalized physiological capabilities, integrated into fields such as medicine, sports, and insurance.
- When was Biogradient founded?
- Biogradient was founded in May 2019.
- Who are the founders of Biogradient?
- The co-founders of Biogradient are Ron Gutterman and Gal Tichon.
- What is the status of Biogradient?
- Biogradient is non-active and ceased to operate in March 2025.
- What kind of system does Biogradient offer?
- Biogradient offers a digital sensor-based system that enables goal-oriented, supervised exercise prescription and adapts to individual schedules and preferences, with human involvement for encouragement and supervision.